|Articles|August 1, 2002

Supplements and Featured Publications

  • Measuring Persistency with Drug Therapy in Glaucoma Management
  • Volume 8
  • Issue 10 Suppl

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

Download PDF: An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

Articles in this issue

over 23 years ago

Measuring Patient Persistency with Drug Therapy Using Methods for the Design and Analysis of Natural History Studies

over 23 years ago

Participating Faculty

over 23 years ago

Introduction

over 23 years ago

Population-Based Persistency Rates for Topical Glaucoma Medications Measured with Pharmacy Claims Data

over 23 years ago

Rates of Discontinuation and Change of Glaucoma Therapy in a Managed Care Setting

over 23 years ago

Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population

over 23 years ago

Measuring Persistency and Intraocular Pressure-Controlled Days in Patients Receiving Topical Glaucoma Medications

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

View more
Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia
On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

View more
Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens
On-Demand Virtual Symposium

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

1.5 Credits / Hematologic Cancer, Hematology, Oncology

View more
Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management
On-Demand Virtual Symposium

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

1.5 Credits / Oncology, Hematology

View more
Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative
On-Demand Virtual Symposium

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology

View more
Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care
On-Demand Virtual Symposium

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

1.5 Credits / HIV/AIDS, Infectious Disease

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text